Share Prices & Company Research

Market News

17 Apr 2019 | 14:43

Smith & Nephew completes acquisition of Osiris for $660m

Smith & Nephew said it had completed its acquisition of regenerative medicine products supplier Osiris for around $660m.

The medical technology group had offered $19.00 per Osiris share in cash.

Osiris delivered revenue of $142.8m for the year through December, up 21% on-year.

At 2:43pm: (LON:SN.) Smith Nephew PLC share price was -16.75p at 1472.25p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.